185 related articles for article (PubMed ID: 10942635)
1. Multi-drug resistant HIV-1.
Omrani AS; Pillay D
J Infect; 2000 Jul; 41(1):5-11. PubMed ID: 10942635
[No Abstract] [Full Text] [Related]
2. Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors.
Hecht FM; Grant RM; Petropoulos CJ; Dillon B; Chesney MA; Tian H; Hellmann NS; Bandrapalli NI; Digilio L; Branson B; Kahn JO
N Engl J Med; 1998 Jul; 339(5):307-11. PubMed ID: 9682043
[No Abstract] [Full Text] [Related]
3. Viral resistance: a major challenge in managing HIV disease.
Boucher CA; Reedijk M
J Biol Regul Homeost Agents; 1995; 9(3):91-4. PubMed ID: 8782014
[No Abstract] [Full Text] [Related]
4. Current insights into reverse transcriptase inhibitor-associated resistance.
Wainberg MA; White AJ
Antivir Ther; 2001; 6 Suppl 2():11-9. PubMed ID: 11678474
[No Abstract] [Full Text] [Related]
5. [Recent challenges and progress in AIDS therapy--emergence of drug resistant HIV-1 variants].
Mitsuya H
Rinsho Ketsueki; 1999 Apr; 40(4):249-54. PubMed ID: 10355129
[No Abstract] [Full Text] [Related]
6. Limits of resistance testing.
D'Aquila RT
Antivir Ther; 2000 Mar; 5(1):71-6. PubMed ID: 10846596
[TBL] [Abstract][Full Text] [Related]
7. HIV resistance: the new enemy.
Colvin R
Common Factor; 1997 Nov; (No 11):6-7. PubMed ID: 11364845
[TBL] [Abstract][Full Text] [Related]
8. Increasing prevalence of HIV-1 reverse transcriptase mutation K65R correlates with tenofovir utilization.
Kagan RM; Merigan TC; Winters MA; Heseltine PN
Antivir Ther; 2004 Oct; 9(5):827-8. PubMed ID: 15535422
[No Abstract] [Full Text] [Related]
9. Clinical utility of resistance testing.
Stebbing J; Gazzard BG
J HIV Ther; 2002 Nov; 7(4):75-9. PubMed ID: 12733604
[No Abstract] [Full Text] [Related]
10. Antiretroviral resistance.
Geretti AM
J HIV Ther; 2006 Dec; 11(4):72-3. PubMed ID: 17578209
[No Abstract] [Full Text] [Related]
11. Vertical transmission of multidrug-resistant human immunodeficiency virus type 1 (HIV-1) and continued evolution of drug resistance in an HIV-1-infected infant.
Johnson VA; Petropoulos CJ; Woods CR; Hazelwood JD; Parkin NT; Hamilton CD; Fiscus SA
J Infect Dis; 2001 Jun; 183(11):1688-93. PubMed ID: 11343221
[TBL] [Abstract][Full Text] [Related]
12. Revisiting the concept of a genetic barrier to resistance.
Rusconi S
J HIV Ther; 2006 Dec; 11(4):81-3. PubMed ID: 17578211
[No Abstract] [Full Text] [Related]
13. Interpretation of resistance assay results.
Miller V
Antivir Ther; 2001; 6 Suppl 2():1-9. PubMed ID: 11678473
[No Abstract] [Full Text] [Related]
14. Drug-resistant reverse transcriptase genotyping and phenotyping of B and non-B subtypes (F and A) of human immunodeficiency virus type I found in Brazilian patients failing HAART.
Caride E; Brindeiro R; Hertogs K; Larder B; Dehertogh P; Machado E; de Sá CA; Eyer-Silva WA; Sion FS; Passioni LF; Menezes JA; Calazans AR; Tanuri A
Virology; 2000 Sep; 275(1):107-15. PubMed ID: 11017792
[TBL] [Abstract][Full Text] [Related]
15. Primary drug resistance in antiretroviral-naïve injection drug users.
Tossonian HK; Raffa JD; Grebely J; Viljoen M; Mead A; Khara M; McLean M; Krishnamurthy A; DeVlaming S; Conway B
Int J Infect Dis; 2009 Sep; 13(5):577-83. PubMed ID: 19111493
[TBL] [Abstract][Full Text] [Related]
16. Understanding transmitted HIV resistance through the experience in the USA.
Taiwo B
Int J Infect Dis; 2009 Sep; 13(5):552-9. PubMed ID: 19136289
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of drug resistance mutations in Spain among both naive and pretreated patients.
Soriano V
Antivir Ther; 1999; 4 Suppl 3():57-63. PubMed ID: 16021872
[TBL] [Abstract][Full Text] [Related]
18. Evolution of HIV-1 multidrug-resistant genotypes during combination therapy and after the cessation of antiretroviral drugs.
Yahi N; Tourrès C; Tivoli N; Colson P; Dhiver C; Quinson AM; Tamalet C
AIDS; 2000 Dec; 14(18):2943-5. PubMed ID: 11153678
[No Abstract] [Full Text] [Related]
19. The clinical significance of viral fitness.
Geretti AM
J HIV Ther; 2005 Mar; 10(1):6-10. PubMed ID: 15951728
[TBL] [Abstract][Full Text] [Related]
20. Mutational patterns in the HIV genome and cross-resistance following nucleoside and nucleotide analogue drug exposure.
Miller V; Larder BA
Antivir Ther; 2001; 6 Suppl 3():25-44. PubMed ID: 11678471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
